KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Crescent Capital BDC (CCAP) EBT (2021 - 2025)

Crescent Capital BDC (CCAP) has disclosed EBT for 5 consecutive years, with $17.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 17.47% year-over-year to $17.0 million, compared with a TTM value of $68.6 million through Dec 2025, down 24.27%, and an annual FY2025 reading of $68.6 million, down 24.27% over the prior year.
  • EBT was $17.0 million for Q4 2025 at Crescent Capital BDC, down from $17.2 million in the prior quarter.
  • Across five years, EBT topped out at $40.2 million in Q4 2023 and bottomed at $12.3 million in Q1 2022.
  • Average EBT over 5 years is $19.8 million, with a median of $17.5 million recorded in 2023.
  • The sharpest move saw EBT soared 43.95% in 2023, then tumbled 48.77% in 2024.
  • Year by year, EBT stood at $13.3 million in 2021, then grew by 17.03% to $15.6 million in 2022, then surged by 157.39% to $40.2 million in 2023, then plummeted by 48.77% to $20.6 million in 2024, then fell by 17.47% to $17.0 million in 2025.
  • Business Quant data shows EBT for CCAP at $17.0 million in Q4 2025, $17.2 million in Q3 2025, and $17.3 million in Q2 2025.